Clinical Trials Related to Colorectal Cancer

Related studies linked through entity extraction aliases.

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Status: SUSPENDED
Phase: PHASE2

A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC

Status: RECRUITING
Phase: N/A

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1

Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions

Status: RECRUITING
Phase: NA

Adaptive Anastomosis for Anterior Resection in Sigmoid and Proximal Rectal Cancer or Premalignant Lesions

Status: RECRUITING
Phase: N/A

Evaluating AI and Human Expert Decisions in Colorectal Cancer

Status: NOT_YET_RECRUITING
Phase: N/A

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

Status: RECRUITING
Phase: NA

The Florida ASCENT Study

Status: RECRUITING
Phase: NA

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

Status: NOT_YET_RECRUITING
Phase: PHASE1

A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea

Status: RECRUITING
Phase: N/A

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

Status: RECRUITING
Phase: PHASE2

Colorectal Cancer in Young Adults: Study of Incidence, Survival, and Prognostic Factors in Tarragona, Spain

Status: COMPLETED
Phase: N/A

Colorectal Cancers :A Retrospective Study

Status: RECRUITING
Phase: N/A

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Status: RECRUITING
Phase: PHASE2

AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors

Status: NOT_YET_RECRUITING
Phase: PHASE1

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Status: RECRUITING
Phase: PHASE2

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Status: RECRUITING
Phase: PHASE2